This is how much the US is spending on Alzheimer's
A new report from the Alzheimer's Association examines how much the US is spending on treating the disease. Image: REUTERS/Thomas Peter
Alzheimer's disease is the only one of the top leading causes of death whose progression can't be slowed down or stopped.
The neurodegenerative disease affects about 5.5 million Americans, a number that's expected to balloon to 13.8 million by 2050.
And the amount spent caring for people with Alzheimer's is expected to reach $259 billion in 2017, according to a report released Tuesday by the Alzheimer's Association.
"Everybody with a brain at risk and needs to care about this," Beth Kallmyer, vice president of constituent services for the Alzheimer’s Association told Business Insider.
The search for a treatment to Alzheimer's hasn't been going well. There are only four approved drugs that treat symptoms of the disease, and several hopeful treatments have failed key studies over the last few months.
So while death rates for illnesses such as HIV and heart disease have dropped over the past 14 years, the Alzheimer's Association noted, Alzheimer's deaths are up 89% over that period.
Still, more drugs are in late-stage trials that could have an impact on the disease, and researchers are pinning hopes on diagnosing the disease early, before symptoms even show up. If any of those treatments pan out, it could change the way we look at the disease and potentially make these statistics a lot less dire.
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
Stay up to date:
United States
Forum Stories newsletter
Bringing you weekly curated insights and analysis on the global issues that matter.